| Financial Year |
March 31 2023 |
| Monetary Funds |
519,061,846.01 |
| Held-for-trading Financial Assets |
646,752,426.81 |
| Notes Receivable |
-- |
| Accounts Receivable |
264,397,435.77 |
| Advances to Suppliers |
8,456,230.91 |
| Other Receivables |
31,883,160.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
397,797,368.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
4,081,377.32 |
| Other Current Assets |
23,987,115.82 |
| Total Current Assets |
1,896,416,962.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
7,045,130.21 |
| Long-term Equity Investment |
50,243,524.70 |
| Investment Properties |
-- |
| Fixed Assetes |
230,856,981.20 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
60,416,371.83 |
| R&D expenses |
-- |
| Goodwill |
134,374,091.63 |
| Long-Term Deferred and Prepaid Expenses |
31,620,056.37 |
| Deferred Income Tax Assets |
56,784,526.53 |
| Other Non-Current Assets |
1,098,271.04 |
| Sub-Total of Non-Current Assets |
643,797,282.36 |
| Total Assets |
2,540,214,244.37 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
197,878,814.68 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,756,377.83 |
| Taxes Payable |
3,329,532.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
72,898,033.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
21,142,014.51 |
| Other Current Liabilities |
4,584,480.47 |
| Sub-Total of Current Liabilities |
343,862,009.47 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
9,635,152.29 |
| Deferred Income Tax Liabilities |
335,069.49 |
| Other Non-Current Liabilities |
79,067,680.00 |
| Sub-Total of Non-Current Liabilities |
114,911,980.16 |
| Total Liabilities |
458,773,989.63 |
| Paid-In Capital(Or Share Stock) |
883,702,186.00 |
| Capital Surplus |
856,424,593.36 |
| Surplus Reserve |
176,939,618.03 |
| LESS:Treasury Stock |
50,024,131.84 |
| Undistributed Profits |
266,250,737.04 |
| Minority Stockholder's Interest |
5,204,513.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,076,235,741.54 |
| Owner's Equity（Stockholder's Equity） |
2,081,440,254.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,540,214,244.37 |
